Elliott Investment Management’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-11,500
Closed -$92.7K 42
2024
Q4
$92.7K Hold
11,500
﹤0.01% 45
2024
Q3
$93.8K Hold
11,500
﹤0.01% 59
2024
Q2
$80.2K Hold
11,500
﹤0.01% 54
2024
Q1
$122K Hold
11,500
﹤0.01% 55
2023
Q4
$92.3K Hold
11,500
﹤0.01% 60
2023
Q3
$94.8K Hold
11,500
﹤0.01% 62
2023
Q2
$92K Sell
11,500
-3,125
-21% -$23K ﹤0.01% 64
2023
Q1
$118K Hold
14,625
﹤0.01% 54
2022
Q4
$91.9K Hold
14,625
﹤0.01% 58
2022
Q3
$101K Buy
+14,625
New +$102K ﹤0.01% 41

Other funds holding BHC

Elliott Investment Management's BHC Position: Q1 2025 in Review

Elliott Investment Management sold out of Bausch Health (BHC) in Q1 2025, closing a stake of 11,500 shares — an estimated $92.7K sold.

Elliott Investment Management first reported a position in BHC in Q3 2022 and held it in 10 quarters. The position peaked at $122K in Q1 2024. 230 funds tracked by Wall St. Rank hold BHC as of Q1 2025.

  • Elliott Investment Management reported no remaining Bausch Health position as of Q1 2025 after selling out during the quarter.
  • Elliott Investment Management sold 11,500 Bausch Health shares in Q1 2025, an estimated $92.7K.
  • Elliott Investment Management first reported a position in Bausch Health in Q3 2022 and held it in 10 quarters.
  • Elliott Investment Management's Bausch Health position peaked at $122K in Q1 2024.
  • 230 funds tracked by Wall St. Rank held Bausch Health as of Q1 2025.

Based on Elliott Investment Management's 13F filing for Q1 2025, filed 15 May 2025.